Title : Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.

Pub. Date : 2011 Jun

PMID : 21693288






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years" follow-up from the University Hospital Munster. Everolimus calcineurin binding protein 1 Homo sapiens
2 Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years" follow-up from the University Hospital Munster. Everolimus calcineurin binding protein 1 Homo sapiens
3 To date, there are only sparse data about long-term calcineurin inhibitor (CNI)-free immunosuppression using everolimus. Everolimus calcineurin binding protein 1 Homo sapiens
4 Reasons for switching to everolimus were side effects of CNI immunosuppression, such as deterioration of kidney function and recurrent rejection episodes. Everolimus calcineurin binding protein 1 Homo sapiens
5 CONCLUSION: CNI-free immunosuppression using everolimus is safe, with excellent efficacy in maintenance of heart transplant recipients. Everolimus calcineurin binding protein 1 Homo sapiens